Gene Review:
Plaur - plasminogen activator, urokinase receptor
Mus musculus
Synonyms:
Cd87, U-PAR, Urokinase plasminogen activator surface receptor, u-PAR, uPAR, ...
Rofstad,
Rasmussen,
Galappathi,
Mathiesen,
Nilsen,
Graff,
Vallera,
Li,
Jin,
Panoskaltsis-Mortari,
Hall,
East,
Baker,
Pryce,
Lijnen,
Cuzner,
Gverić,
Piguet,
Da Laperrousaz,
Vesin,
Tacchini-Cottier,
Senaldi,
Grau,
Abbas Rizvi,
Li,
Song,
Qu,
Raja,
Morgenstern,
Apostolidis,
Allen,
Herbert,
Lamarche,
Carmeliet,
Boyd,
Kim,
Wang,
Jones,
Gallick,
Piguet,
Vesin,
Da Laperousaz,
Rochat,
Renckens,
Roelofs,
Florquin,
Poll,
Carmeliet,
Moons,
Dewerchin,
Rosenberg,
Herbert,
Lupu,
Collen,
- The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network. Webb, C.P., Hose, C.D., Koochekpour, S., Jeffers, M., Oskarsson, M., Sausville, E., Monks, A., Vande Woude, G.F. Cancer Res. (2000)
- Adenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growth. Mohan, P.M., Chintala, S.K., Mohanam, S., Gladson, C.L., Kim, E.S., Gokaslan, Z.L., Lakka, S.S., Roth, J.A., Fang, B., Sawaya, R., Kyritsis, A.P., Rao, J.S. Cancer Res. (1999)
- A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitis. East, E., Baker, D., Pryce, G., Lijnen, H.R., Cuzner, M.L., Gverić, D. Am. J. Pathol. (2005)
- The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. Bugge, T.H., Suh, T.T., Flick, M.J., Daugherty, C.C., Rømer, J., Solberg, H., Ellis, V., Danø, K., Degen, J.L. J. Biol. Chem. (1995)
- A direct link between expression of urokinase plasminogen activator receptor, growth rate and oncogenic transformation in mouse embryonic fibroblasts. Mazzieri, R., Furlan, F., D'Alessio, S., Zonari, E., Talotta, F., Verde, P., Blasi, F. Oncogene (2007)
- CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer. Guo, Z., Linn, J.F., Wu, G., Anzick, S.L., Eisenberger, C.F., Halachmi, S., Cohen, Y., Fomenkov, A., Hoque, M.O., Okami, K., Steiner, G., Engles, J.M., Osada, M., Moon, C., Ratovitski, E., Trent, J.M., Meltzer, P.S., Westra, W.H., Kiemeney, L.A., Schoenberg, M.P., Sidransky, D., Trink, B. Nat. Med. (2004)
- Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo. May, A.E., Kanse, S.M., Lund, L.R., Gisler, R.H., Imhof, B.A., Preissner, K.T. J. Exp. Med. (1998)
- Targeting urokinase-type plasminogen activator receptor on human glioblastoma tumors with diphtheria toxin fusion protein DTAT. Vallera, D.A., Li, C., Jin, N., Panoskaltsis-Mortari, A., Hall, W.A. J. Natl. Cancer Inst. (2002)
- Generation and characterization of urokinase receptor-deficient mice. Dewerchin, M., Nuffelen, A.V., Wallays, G., Bouché, A., Moons, L., Carmeliet, P., Mulligan, R.C., Collen, D. J. Clin. Invest. (1996)
- Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells. Nip, J., Rabbani, S.A., Shibata, H.R., Brodt, P. J. Clin. Invest. (1995)
- Preclinical studies of bismuth-213 labeled plasminogen activator inhibitor type 2 (PAI2) in a prostate cancer nude mouse xenograft model. Abbas Rizvi, S.M., Li, Y., Song, E.Y., Qu, C.F., Raja, C., Morgenstern, A., Apostolidis, C., Allen, B.J. Cancer Biol. Ther. (2006)
- Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor. Rofstad, E.K., Rasmussen, H., Galappathi, K., Mathiesen, B., Nilsen, K., Graff, B.A. Cancer Res. (2002)
- Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases. Margheri, F., D'Alessio, S., Serratí, S., Pucci, M., Annunziato, F., Cosmi, L., Liotta, F., Angeli, R., Angelucci, A., Gravina, G.L., Rucci, N., Bologna, M., Teti, A., Monia, B., Fibbi, G., Del Rosso, M. Gene Ther. (2005)
- Urokinase-type plasminogen activator receptor plays a role in neutrophil migration during lipopolysaccharide-induced peritoneal inflammation but not during Escherichia coli-induced peritonitis. Renckens, R., Roelofs, J.J., Florquin, S., Poll, T. J. Infect. Dis. (2006)
- Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Bugge, T.H., Flick, M.J., Danton, M.J., Daugherty, C.C., Romer, J., Dano, K., Carmeliet, P., Collen, D., Degen, J.L. Proc. Natl. Acad. Sci. U.S.A. (1996)
- FGF-2 stimulates migration of Kaposi's sarcoma-like vascular cells by HGF-dependent relocalization of the urokinase receptor. Cavallaro, U., Wu, Z., Di Palo, A., Montesano, R., Pepper, M.S., Maier, J.A., Soria, M.R. FASEB J. (1998)
- Characterization of the functional epitope on the urokinase receptor. Complete alanine scanning mutagenesis supplemented by chemical cross-linking. Gårdsvoll, H., Gilquin, B., Le Du, M.H., Ménèz, A., Jørgensen, T.J., Ploug, M. J. Biol. Chem. (2006)
- Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice. Piguet, P.F., Da Laperrousaz, C., Vesin, C., Tacchini-Cottier, F., Senaldi, G., Grau, G.E. Infect. Immun. (2000)
- Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor. Harvey, M.B., Leco, K.J., Arcellana-Panlilio, M.Y., Zhang, X., Edwards, D.R., Schultz, G.A. Development (1995)
- Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein. Zhang, G., Cai, X., López-Guisa, J.M., Collins, S.J., Eddy, A.A. J. Am. Soc. Nephrol. (2004)
- Role of plasminogen activators and urokinase receptor in platelet kinetics. Piguet, P.F., Vesin, C., Da Laperousaz, C., Rochat, A. Hematol. J. (2000)
- Binding of urokinase to low density lipoprotein-related receptor (LRP) regulates vascular smooth muscle cell contraction. Nassar, T., Haj-Yehia, A., Akkawi, S., Kuo, A., Bdeir, K., Mazar, A., Cines, D.B., Higazi, A.A. J. Biol. Chem. (2002)
- Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice. Carmeliet, P., Moons, L., Dewerchin, M., Rosenberg, S., Herbert, J.M., Lupu, F., Collen, D. J. Cell Biol. (1998)
- Urokinase and tissue-type plasminogen activator are required for the mitogenic and chemotactic effects of bovine fibroblast growth factor and platelet-derived growth factor-BB for vascular smooth muscle cells. Herbert, J.M., Lamarche, I., Carmeliet, P. J. Biol. Chem. (1997)
- Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation. Tarui, T., Akakura, N., Majumdar, M., Andronicos, N., Takagi, J., Mazar, A.P., Bdeir, K., Kuo, A., Yarovoi, S.V., Cines, D.B., Takada, Y. Thromb. Haemost. (2006)
- A urokinase-derived peptide (A6) increases survival of mice bearing orthotopically grown prostate cancer and reduces lymph node metastasis. Boyd, D.D., Kim, S.J., Wang, H., Jones, T.R., Gallick, G.E. Am. J. Pathol. (2003)
- Plasminogen mediates the pathological effects of urokinase-type plasminogen activator overexpression. Bolon, I., Zhou, H.M., Charron, Y., Wohlwend, A., Vassalli, J.D. Am. J. Pathol. (2004)
- Evidence for similar expression of protein C inhibitor and the urokinase-type plasminogen activator system during mouse testis development. Odet, F., Guyot, R., Leduque, P., Le Magueresse-Battistoni, B. Endocrinology (2004)
- Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy. Zhang, G., Kim, H., Cai, X., López-Guisa, J.M., Alpers, C.E., Liu, Y., Carmeliet, P., Eddy, A.A. J. Am. Soc. Nephrol. (2003)
- Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator. Solberg, H., Løber, D., Eriksen, J., Ploug, M., Rønne, E., Behrendt, N., Danø, K., Høyer-Hansen, G. Eur. J. Biochem. (1992)
- Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor. Zheng, Q., Tang, Z.Y., Xue, Q., Shi, D.R., Song, H.Y., Tang, H.B. J. Cancer Res. Clin. Oncol. (2000)